Abstract N6-methyladenosine (m6A) is one of the most important epigenetic regulation of
RNAs, such as lncRNAs. However, the underlying regulatory mechanism of m6A in diabetic …

N6-methyladenosine (m6A) methylation in RNA is a dynamic and reversible modification
regulated by methyltransferases and demethylases, which has been reported to participate …

Diabetes cardiomyopathy (DCM) is a critical complication of long-term chronic diabetes
mellitus and is characterized by myocardial fibrosis and myocardial hypertrophy. It has been …

Background/Aims: Diabetic cardiomyopathy (DCM) is a common complication of diabetes
and can cause heart failure, arrhythmia and sudden death. The pathogenesis of DCM …

We previously established a rat model of diabetic cardiomyopathy (DCM) and found that the
expression of long non-coding RNA myocardial infarction–associated transcript (MIAT) was …

Aims Doxorubicin (DOX), a widely used powerful chemotherapeutic component for cancer
treatment, can give rise to severe cardiotoxicity that limits its clinical use. Pyroptosis is …

Abstract Aims N6-Methyladenosine (m 6 A), one of the important epigenitic modifications, is
very commom in messenger RNAs (mRNAs) of eukaryotes, and has been involved in …

Objective Myocardial ischemia/reperfusion (MI/R) injury is a complicated pathophysiological
process associated with cardiomyocyte pyroptosis. Methyltransferase-like protein 3 …

Ferroptosis is an iron-dependent and phospholipid peroxidation-mediated cell death, which
has been identified to be involved in sepsis-induced injury. However, the in-depth molecular …

Objective: Extensive studies have shown that ERS may be implicated in the pathogenesis of
DCM. We explored the therapeutic effects of lncRNAH19 on DCM and its effect on ERS …